63.47 0.00 (0.00%)
After hours: 4:32PM EST
|Bid||55.00 x 1400|
|Ask||75.00 x 1100|
|Day's Range||63.28 - 64.84|
|52 Week Range||60.42 - 75.00|
|Beta (3Y Monthly)||1.36|
|PE Ratio (TTM)||69.52|
|Earnings Date||Nov 19, 2018|
|Forward Dividend & Yield||0.60 (0.92%)|
|1y Target Est||79.08|
Agilent Technologies Inc. (NYSE:A) today announced that its board of directors has increased the company’s quarterly dividend to 16.4 cents per share of common stock. Agilent Technologies Inc. (NYSE:A) is a global leader in life sciences, diagnostics, and applied chemical markets. With more than 50 years of insight and innovation, Agilent instruments, software, services, solutions, and people provide trusted answers to its customers' most challenging questions.
Agilent (A) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nine companies have majority ‘buy’ ratings, with upside potential of as much as 123%, according to analysts.
The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Align Technology, Inc. (“Align” or “the Company”) (NASDAQ: ALGN) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Investors who purchased the Company's shares between July 25, 2018 and October 24, 2018, inclusive (the “Class Period”), are encouraged to contact the firm before January 4, 2019. We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge.
Agilent Technologies Inc. (NYSE:A) today introduced the Cary 3500 UV-Vis system, an innovative spectrophotometer designed to help life science, pharma and biopharma research communities simplify their analyses, optimize laboratory productivity, and ultimately help bring new therapeutics to market faster. Agilent will showcase the Cary 3500 UV-Vis system at analytica China, being held October 31 – November 2, 2018, in Shanghai, China.
Agilent Technologies Inc. (NYSE:A) today announced the introduction of Agilent OnePGT, a genome-wide, next-generation sequencing (NGS) solution for preimplantation genetic testing (PGT). Agilent will showcase the OnePGT solution at the 5th Congress on Controversies in Preconception, Preimplantation and Prenatal Genetic Diagnosis (CoGEN), November 1-3, 2018 in Paris, France. This innovative solution provides fertility specialists the ability to more easily achieve comprehensive PGT data in which to support enhanced embryo ranking, identifying the best quality embryos for transfer.
NEW YORK, Oct. 31, 2018 -- In new independent research reports released early this morning, Market Source Research released its latest key findings for all current investors,.
Agilent Technologies Inc. (NYSE:A) today announced that it sent a letter to the Division of Corporation Finance of the U.S. Securities and Exchange Commission (SEC) regarding misstatements in the S-1 Registration Statement filed by Twist Bioscience Corp. Ms. Leproust admitted under oath that she secretly became Twist’s CEO 17 months prior to leaving Agilent.
Agilent Technologies Inc. (NYSE:A) is pleased to announce Eric Gerber as the company’s new senior vice president of strategy and corporate development, reporting to Agilent President and CEO, Mike McMullen, effective November 1, 2018. Gerber will lead the corporate development team in identifying, developing and evaluating M&A plans globally while collaborating with the businesses groups to help drive critical growth initiatives across the company.
Agilent Technologies Inc. (NYSE:A) today announced that it has been recognized by Forbes as one of the World’s Best Employers. This marks the second consecutive year that Agilent has been named to this elite global list. Agilent is ranked number 125 of the 500 companies on the list.
A New Zealand company working to develop ultraviolet light as an agricultural tool is the third tenant in the Bayer Crop Science CoLaborator in West Sacramento.
With the stock market engulfed in turmoil and increased volatility, investors may be on the lookout for stocks that can deliver big short-term gains. Morgan Stanley names 8 stocks for which they have high conviction about a positive near term view: Tesla Inc. ( TSLA), Zendesk Inc. ( ZEN), SBA Communications Corp. ( SBAC), Molina Healthcare Inc. ( MOH), FirstEnergy Corp. ( FE), CyberArk Software Ltd. ( CYBR), Bausch Health Companies Inc. ( BHC) and Agilent Technologies Inc. ( A). The key catalysts that Morgan Stanley sees for upside in these stocks are summarized in the table below.
Agilent Technologies Inc. will release fourth-quarter fiscal 2018 financial results after the stock market closes on November 19. The company will host a live webcast of its investor conference call in listen-only mode.
Today we’re going to take a look at the well-established Agilent Technologies Inc (NYSE:A). The company’s stock received a lot of attention from a substantial price movement on the NYSE Read More...
AVX's fiscal second-quarter results are likely to benefit from acquisitions and strength in the automotive market. However, weakness in the smartphone market might impact its results.
Agilent Technologies has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock.